文献速递临床试验与 GCP

颈动脉内膜剥脱术中超声溶栓预防脑梗死试验(SONOBIRDIE):随机对照试验研究方案

SONOlysis in prevention of Brain InfaRctions During Internal carotid Endarterectomy (SONOBIRDIE) trial - study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-01-17

SONOBIRDIE 为多中心、随机、双盲、假对照试验,纳入颈内动脉狭窄至少 70% 并接受颈动脉内膜剥脱术的患者,评估 2 MHz 诊断探头持续经颅多普勒超声溶栓能否减少术后 30 天内卒中或短暂性脑缺血发作及术后 24 小时脑 MRI 新发缺血灶。

要点

  • SONOBIRDIE 试验采用多中心、随机、双盲、假对照设计评估超声溶栓。
  • 纳入标准为症状性或无症状性颈内动脉狭窄至少 70% 且拟行颈动脉内膜剥脱术。
  • 主要终点为术后 30 天内卒中或短暂性脑缺血发作及术后 24 小时脑 MRI 新发缺血灶。

核心结论

  • 使用广泛可得且廉价的超声溶栓减少颈动脉内膜剥脱术围术期并发症,可能显著提高手术安全性并扩展手术适应证。

研究设计与样本

  • 多中心、随机、双盲、假对照试验,连续入组患者按计算机生成的 1:1 比例随机分配至超声溶栓组或对照组(假操作)。
  • 研究纳入因症状性或无症状性颈内动脉狭窄至少 70% 而拟行颈动脉内膜剥脱术的患者,要求颞骨超声窗充分、年龄 40 至 85 岁、功能独立并签署知情同意。
  • 预试验计算显示每组至少需 704 例患者,设 α 值 0.05(双侧)、β 值 0.8,并假设 10% 失访或拒绝参与(预计 39 个终点事件)。

主要发现

  • 主要终点为颈动脉内膜剥脱术后 30 天内卒中或短暂性脑缺血发作的发生率,以及术后 24 小时脑 MRI 新发缺血灶的发生率。
  • 次要终点包括术后 30 天内死亡、任何卒中或心肌梗死的发生,术后 1 年认知功能相对术前评分的变化,以及术后脑 MRI 新发病灶数量和 ≥0.5 mL 新发病灶的发生。
  • 分析将采用描述性统计及线性/逻辑多重回归模型,临床相关性以相对风险降低、绝对风险降低和需治疗人数衡量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid endarterectomy (CEA) is a beneficial procedure for selected patients with an internal carotid artery (ICA) stenosis. Surgical risk of CEA varies from between 2 and 15%. The aim of the study is to demonstrate the safety and effectiveness of sonolysis (continual transcranial Doppler monitoring, TCD) using a 2-MHz diagnostic probe with maximal diagnostic energy on the reduction of the incidence of stroke, transient ischemic attack (TIA) and brain infarction detected using magnetic resonance imaging (MRI) by the activation of the endogenous fibrinolytic system during CEA. METHODS/DESIGN: Design: a multicenter, randomized, double-blind, sham-controlled trial. SCOPE: international, multicenter trial for patients with at least 70% symptomatic or asymptomatic ICA stenosis undergoing CEA. INCLUSION CRITERIA: patients with symptomatic or asymptomatic ICA stenosis of at least 70% are candidates for CEA; a sufficient temporal bone window for TCD; aged 40-85 years, functionally independent; provision of signed informed consent. Randomization: consecutive patients will be assigned to the sonolysis or control (sham procedure) group by computer-generated 1:1 randomization. Prestudy calculations showed that a minimum of 704 patients in each group is needed to reach a significant difference with an alpha value of 0.05 (two-tailed) and a beta value of 0.8 assuming that 10% would be lost to follow-up or refuse to participate in the study (estimated 39 endpoints). ENDPOINTS: the primary endpoint is the incidence of stroke or TIA during 30 days after CEA and the incidence of new ischemic lesions on brain MRI performed 24 h after CEA in the sonolysis and control groups. Secondary endpoints are occurrence of death, any stroke, or myocardial infarction within 30 days, changes in cognitive functions 1 year post procedure related to pretreatment scores, and number of new lesions and occurrence of new lesions ≥0.5 mL on post-procedural brain MRI. ANALYSIS: descriptive statistics and linear/logistic multiple regression models will be performed. Clinical relevance will be measured as relative risk reduction, absolute risk reduction and the number needed to treat. DISCUSSION: Reduction of the periprocedural complications of CEA using sonolysis as a widely available and cheap method may significantly increase the safety of CEA and extend the indication criteria for CEA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02398734 . Registered on 20 March 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hrbáč T, Netuka D, Beneš V, et al. SONOlysis in prevention of Brain InfaRctions During Internal carotid Endarterectomy (SONOBIRDIE) trial - study protocol for a randomized controlled trial. Trials. 2017. PMID: 28095924. doi:10.1186/s13063-016-1754-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。